GW&K Investment Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-287,865
Closed -$368K 502
2022
Q3
$368K Sell
287,865
-278,610
-49% -$607K ﹤0.01% 327
2022
Q2
$1.39M Buy
+566,475
New +$2.69M 0.02% 321

Other funds holding RNLX

GW&K Investment Management's RNLX Position: Q4 2022 in Review

GW&K Investment Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2022, closing a stake of 287,865 shares — an estimated $368K sold.

GW&K Investment Management first reported a position in RNLX in Q2 2022 and held it in 2 quarters. The position peaked at $1.39M in Q2 2022. 21 funds tracked by Wall St. Rank hold RNLX as of Q4 2022.

  • GW&K Investment Management reported no remaining Renalytix plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • GW&K Investment Management sold 287,865 Renalytix plc American Depositary Shares shares in Q4 2022, an estimated $368K.
  • GW&K Investment Management first reported a position in Renalytix plc American Depositary Shares in Q2 2022 and held it in 2 quarters.
  • GW&K Investment Management's Renalytix plc American Depositary Shares position peaked at $1.39M in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2022.

Based on GW&K Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.